ZORELEVEZ Trademark

Trademark Overview


On Thursday, July 24, 2025, a trademark application was filed for ZORELEVEZ with the United States Patent and Trademark Office. The USPTO has given the ZORELEVEZ trademark a serial number of 99300923. The federal status of this trademark filing is REGISTERED as of Tuesday, January 6, 2026. This trademark is owned by Merck Sharp & Dohme B.V.. The ZORELEVEZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
zorelevez

General Information


Serial Number99300923
Word MarkZORELEVEZ
Filing DateThursday, July 24, 2025
Status700 - REGISTERED
Status DateTuesday, January 6, 2026
Registration Number8095987
Registration DateTuesday, January 6, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme B.V.
Party Type30 - Original Registrant
Legal Entity Type26 - NOT AVAILABLE
AddressHAARLEM 2031BN
NL

Party NameMerck Sharp & Dohme B.V.
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressHAARLEM 2031BN
NL

Party NameMerck Sharp & Dohme B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressHAARLEM 2031BN
NL

Trademark Events


Event DateEvent Description
Thursday, July 24, 2025NEW APPLICATION ENTERED
Thursday, July 24, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 25, 2025ASSIGNED TO EXAMINER
Tuesday, July 29, 2025SUSPENSION LETTER WRITTEN
Tuesday, July 29, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, July 29, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 9, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 9, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, January 6, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED